Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UK-369,003 and Cialis in Erectile Dysfunction
NCT00174486Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2005
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of gisadenafil besylate in erectile dysfunction (ED) (3 arms), sponsored by Pfizer. Primary endpoints: Assessment of duration of action and Assessment of safety & toleration. Started Feb 2005; status: completed.
02
Drugs
gisadenafil besylate
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00174486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174486.